Association of estrogen receptor α gene polymorphisms with cytokine genes expression in systemic lupus erythematosus

Croatian Medical Journal

Volumn 50, Issue 2, 2009, Pages 117-123

  Lu, Zhi Ming ^a   Wang, Zi E ^a   Liu, Yi Qing ^a   Wu, Chun Xiao ^a   Wang, Chang Yin ^a   Zhang, Bing Chang ^a   Shao, Song ^a   Jiao, Yu Lian ^a   Che, Zhi Xiang ^a   Chen, Zi Jiang ^a   Zhao, Yue Ran ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYTOKINE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK FACTORS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 67651021038     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.117     Document Type: Article

References (28)

1. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev. 1995; 144: 157-93. Medline:7590812 doi:10.1111/j.1600-065X.1995.tb00069.x
2. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985; 37: 269-390. Medline:3890479 doi:10.1016/S0065-2776 (08) 60342-9
3. Walker SE. The importance of sex hormones in systemic lupus erythematosus, In: Wallace DJ, Hahn BH, editors. dubois' lupus erythematosus. 6th ed. Philadelphia (Pa) : Lippincott Williams and Wilkins; 2002. p. 307-18.
4. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-a. Nature. 1986; 320: 134-9. Medline:3754034 doi:10.1038/320134a0
5. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary dna. Science. 1986; 231: 1150-4. Medline:3753802 doi:10.1126/science.3753802
6. Kassi En, Vlachoyiannopoulos PG, Moutsopoulos HM, Sekeris CE, Moutsatsou P. Molecular analysis of estrogen receptor alpha and beta in lupus patients. Eur J Clin invest. 2001; 31: 86-93. Medline:11168443 doi:10.1046/j.1365-2362.2001. 00762.x (Pubitemid 32151126)
7. Johansson M, Arlestig L, Moller B, Smedby T, Rantapaa-dahlqvist S. Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis. 2005; 64: 1611-7. Medline:15817658 doi:10.1136/ard.2004.032425 (Pubitemid 41532046)
8. Lee YJ, Shin KS, Kang SW, Lee CK, Yoo B, Cha HS, et al. Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis. 2004; 63: 1244-9. Medline:15361380 doi:10.1136/ard.2003.012583 (Pubitemid 39273502)
9. Ogawa N, Itoh M, Goto Y. Abnormal production of B cell growth factor in patients with systemic lupus erythematosus. Clin Exp Immunol. 1992; 89: 26-31. Medline:1628424
10. Linker-israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous iL-6 in systemic lupus erythematosus. a putative role in pathogenesis. J immunol. 1991; 147: 117-23. Medline:2051017
11. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine netw. 1993; 4: 421-7. Medline:8186374 (Pubitemid 24062020)
12. Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, Longy-Boursier M, et al. Th1 (iL-2, interferon-gamma (iFn-gamma)) and th2 (iL-10, iL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp immunol. 1999; 115: 189-95. Medline:9933441 doi:10.1046/j.1365-2249.1999.00766.x (Pubitemid 29030384)
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271-7. Medline:7138600 doi:10.1002/art.1780251101 (Pubitemid 13221242)
14. Hochberg MC. Updating the american College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725. Medline:9324032 doi:10.1002/art.1780400928
15. Ushiyama T, Ueyama H, Inoue K, Nishioka J, Ohkubo I, Hukuda S. Estrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol. 1998; 25: 134-7. Medline:9458216
16. Chomczynski P, Sacchi N. The single-step method of Rna isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006; 1: 581-5. Medline:17406285 doi:10.1038/nprot.2006.83
17. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992; 89: 1890-3. Medline:1371884 doi:10.1073/pnas.89.5.1890
18. Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, Ye YM, et al. Cytokine iL-6 and iL-10 as biomarkers in systemic lupus erythematosus. J Clin immunol. 2007; 27: 461-6. Medline:17587156 doi:10.1007/s10875-007-9104-0 (Pubitemid 47319257)
19. Funauchi M, Ikoma S, Enomoto H, Horiuchi A. Decreased th1-like and increased th2-like cells in systemic lupus erythematosus. Scand J Rheumatol. 1998; 27: 219-24. Medline:9645418 doi:10.1080/030097498440859 (Pubitemid 28267115)
20. Chen S, Hu D, Shi X, Shen N, Gu Y, Bao C. The relationship between th1/th2-type cells and disease activity in patients with systemic lupus erythematosus. Chin Med J (Engl). 2000; 113: 877-80. Medline:11775831
21. Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Takasaki Y, et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th1-and Th2-derived cytokines. Clin Exp immunol. 1999; 116: 169-73. Medline:10209522 doi:10.1046/j.1365-2249.1999.00862.x (Pubitemid 29170021)
22. Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998; 102: 2146-55. Medline:9854050 doi:10.1172/JCi5084
23. Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst. 1995; 87: 446-51. Medline:7861463 doi:10.1093/jnci/87.6.446
24. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Borresen AL. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet. 1994; 94: 665-70. Medline:7989041
25. Mizunuma H, Hosoi T, okano H, Soda M, Tokizawa T, Kagami I, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre-and postmenopausal women. Bone. 1997; 21: 379-83. Medline:9356730 doi:10.1016/S8756-3282 (97) 00178-6
26. Lehrer S, Rabin J, Kalir T, Schachter BS. Estrogen receptor variant and hypertension in women. Hypertension. 1993; 21: 439-41. Medline:8458645
27. Carling T, Rastad J, Kindmark A, Lundgren E, Ljunghall S, Akerstrom G. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery. 1997; 122: 1101-6. Medline:9426425 doi:10.1016/S0039-6060 (97) 90214-2
28. Duits AJ, Bootsma H, Derksen RH, Spronk PE, Kater L, Kallenberg CG, et al. Skewed distribution of IgG Fc receptor iia (Cd32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 1995; 38: 1832-6. Medline:8849356 doi:10.1002/art.1780381217 (Pubitemid 26010285)